Application Nr Approved Date Route Status External Links
NDA210595 None Respiratory (inhalation) None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Duaklir Pressair Is A Combination Of Aclidinium Bromide (an Anticholinergic) And Formoterol Fumarate (a Laba) Indicated For The Maintenance Treatment Of Patients With Chronic Obstructive Pulmonary Disease (copd). Limitations Of Use : Duaklir Pressair Is Not Indicated For The Relief Of Acute Bronchospasm Or For The Treatment Of Asthma [see Warnings And Precautions (5.1, 5.4) ] . Duaklir Pressair Is A Combination Of Aclidinium Bromide An Anticholinergic, And Formoterol Fumarate, A Long-Acting Beta 2 -Adrenergic Agonist (laba) Indicated For The Maintenance Treatment Of Patients With Chronic Obstructive Pulmonary Disease (copd). (1) Limitations Of Use : Not Indicated For The Relief Of Acute Bronchospasm Or For The Treatment Of Asthma. (1, 5.4).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments